Ionis Pharmaceuticals (IONS) PT Lowered to $70 at Piper Jaffray
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $60.38 +0.03%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Piper Jaffray analyst Tyler Van Buren lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $70.00 (from $75.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- TETRA Technologies Inc. (TTI) PT Lowered to $10 at Northland
- Edison International (EIX) PT Lowered to $63 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
